Bhaskar Dasgupta Selected Research

Systemic Juvenile Rheumatoid Arthritis

1/2017

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bhaskar Dasgupta Research Topics

Disease

26	Giant Cell Arteritis (Horton Disease) 01/2022 - 09/2007
7	Rheumatoid Arthritis 01/2021 - 04/2008
7	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2019 - 08/2010
5	Pain (Aches) 01/2016 - 06/2007
4	Rheumatic Diseases (Rheumatism) 01/2021 - 08/2014
4	Necrosis 01/2021 - 08/2014
4	Vasculitis (Vasculitides) 09/2018 - 01/2016
4	Fatigue 01/2018 - 01/2015
3	Shoulder Pain 04/2012 - 03/2011
2	Acute-Phase Reaction 01/2020 - 06/2007
2	Hypertension (High Blood Pressure) 01/2018 - 11/2011
2	Osteoporosis 01/2018 - 01/2016
2	Infections 01/2018 - 01/2016
2	Diabetes Mellitus 01/2018 - 01/2016
2	Gout 09/2017 - 07/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2015
1	Virus Diseases (Viral Diseases) 01/2021
1	Hepatitis 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2018
1	Cataract (Cataracts) 01/2018
1	Chronic Renal Insufficiency 09/2017
1	Neurosarcoidosis 03/2017
1	Arthritis (Polyarthritis) 01/2017
1	Systemic Juvenile Rheumatoid Arthritis 01/2017
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2017
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Weight Gain 10/2015
1	Disease Susceptibility (Diathesis) 04/2015
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2015
1	Long Term Adverse Effects 01/2013
1	Arthralgia (Joint Pain) 04/2012
1	Atherosclerosis 11/2011
1	Synovitis 03/2011
1	Headache (Headaches) 03/2011
1	Granuloma 11/2010
1	Inclusion Body Myositis 10/2010
1	Dermatomyositis (Dermatopolymyositis) 10/2010
1	Muscular Diseases (Myopathy) 10/2010
1	Polymyositis 10/2010
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2010

Drug/Important Bio-Agent (IBA)

11	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2013
9	GlucocorticoidsIBA 01/2020 - 10/2015
8	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2013
6	SteroidsIBA 03/2020 - 06/2007
5	golimumab FDA Link 01/2016 - 04/2008
5	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2015 - 10/2008
4	C-Reactive ProteinIBA 01/2020 - 03/2011
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 08/2014
3	Biological ProductsIBA 01/2021 - 01/2015
3	CytokinesIBA 01/2021 - 11/2010
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 11/2010
3	Monoclonal AntibodiesIBA 01/2017 - 07/2009
2	Leflunomide (Arava)FDA LinkGeneric 01/2022 - 10/2021
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 07/2009
2	InterleukinsIBA 10/2019 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 10/2019 - 01/2018
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2017 - 07/2015
2	Methylprednisolone FDA LinkGeneric 09/2017 - 10/2015
2	interleukin-6 receptor alphaIBA 01/2017 - 01/2017
2	Amino Acids FDA Link 07/2015 - 04/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2010 - 07/2007
2	Methotrexate (Mexate)FDA LinkGeneric 07/2009 - 04/2008
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	mavrilimumabIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	sirukumabIBA 12/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 09/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2017
1	Infliximab (Remicade)FDA Link 03/2017
1	Biosimilar PharmaceuticalsIBA 03/2017
1	PlasminogenIBA 01/2017
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2016
1	InterferonsIBA 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 07/2015
1	Antihypertensive Agents (Antihypertensives)IBA 01/2015
1	Tumor Necrosis Factor InhibitorsIBA 09/2014
1	olokizumabIBA 09/2014
1	SR-ATIBA 01/2013
1	Rheumatoid FactorIBA 04/2012
1	Anti-Citrullinated Protein AntibodiesIBA 04/2012
1	ORALIT (ORS)IBA 11/2011
1	Fibrinogen (Factor I)FDA Link 03/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010
1	Troponin T (Troponin T1)IBA 10/2010
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2009
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	E-SelectinIBA 07/2009
1	Interleukin-18 (Interleukin 18)IBA 07/2009

Therapy/Procedure

12	Therapeutics 01/2021 - 07/2009
1	Biological Therapy 01/2021
1	Remission Induction 01/2020
1	Polypharmacy 01/2016